Comorbid major depressive disorder as a prognostic factor in cocaine-abusing buprenorphine-maintained patients treated with desipramine and contingency management

American Journal of Drug and Alcohol Abuse

Volumn 29, Issue 3, 2003, Pages 497-514

  Gonzalez, Gerardo ^a   Feingold, Alan ^a,b   Oliveto, Alison ^a   Gonsai, Kishor ^a   Kosten, Thomas R ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PRIVATE PRACTICE   (United States)

Author keywords

Buprenorphine; Clinical trial; Cocaine; Depression; Desipramine; Opioids; Pharmacotherapy

Indexed keywords

ANXIOLYTIC AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; BENZOYLECGONINE; BUPRENORPHINE; CANNABIS; CENTRAL STIMULANT AGENT; COCAINE; DESIPRAMINE; METHADONE; OPIATE; PLACEBO; SEDATIVE AGENT;

ADULT; AGED; ARTICLE; BEHAVIOR THERAPY; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION INVENTORY; CLINICAL FEATURE; CLINICAL TRIAL; COCAINE DEPENDENCE; COMORBIDITY; CONTINGENCY MANAGEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG URINE LEVEL; FEMALE; GENDER; HAMILTON SCALE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MARRIAGE; OPIATE ADDICTION; OUTPATIENT; PROGNOSIS; PSYCHIATRIC DIAGNOSIS; PSYCHOLOGIC ASSESSMENT; PSYCHOLOGIC TEST; RANDOMIZED CONTROLLED TRIAL; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE; STRUCTURED CLINICAL INTERVIEW FOR DSM IV; TREATMENT INDICATION; TREATMENT OUTCOME; URINALYSIS; WITHDRAWAL SYNDROME;

ADULT; AGED; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BUPRENORPHINE; COCAINE-RELATED DISORDERS; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; DESIPRAMINE; DIAGNOSIS, DUAL (PSYCHIATRY); DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; NARCOTIC ANTAGONISTS; OPIOID-RELATED DISORDERS; PROGNOSIS; PSYCHIATRIC STATUS RATING SCALES; TREATMENT OUTCOME;

EID: 0041333076     PISSN: 00952990     EISSN: None     Source Type: Journal    
DOI: 10.1081/ADA-120023455     Document Type: Article

References (37)

1. Rosenblum A, Magura S, Palij M, Foote J, Handelsman L, Stimmel B. Enhanced treatment outcomes for cocaine-using methadone patients. Drug Alcohol Depend 5-3-1999; 54(3):207-218.
2. DeMaria PA Jr, Sterling R, Weinstein SP. The effect of stimulant and sedative use on treatment outcome of patients admitted to methadone maintenance treatment. Am J Addict 2000; 9(2):145-153.
3. Rounsaville BJ, Tierney T, Crits-Christoph K, Weissman MM, Kleber HD. Predictors of outcome in treatment of opiate addicts: evidence for the multidimensional nature of addicts' problems. Compr Psychiatry 1982; 23(5):462-478.
4. Compton WM III, Cottler LB, Ben Abdallah A, Phelps DL, Spitznagel EL, Horton JC. Substance dependence and other psychiatric disorders among drug dependent subjects: race and gender correlates. Am J Addict 2000; 9(2):113-125.
5. Myers JK, Weissman MM, Tischler GL, Holzer CE III, Leaf PJ, Orvaschel H, Anthony JC, Boyd JH, Burke JD Jr, Kramer M. Six-month prevalence of psychiatric disorders in three communities 1980 to 1982. Arch Gen Psychiatry 1984; 41(10):959-967.
6. Rounsaville BJ, Anton SF, Carroll K, Budde D, Prusoff BA, Gawin F. Psychiatric diagnoses of treatment-seeking cocaine abusers. Arch Gen Psychiatry 1991; 48(1):43-51.
7. Uslaner J, Kalechstein A, Richter T, Ling W, Newton T. Association of depressive symptoms during abstinence with the subjective high produced by cocaine. Am J Psychiatry 1999; 156(9):1444-1446.
8. Sofuoglu M, Brown S, Babb DA, Hatsukami DK. Depressive symptoms modulate the subjective and physiological response to cocaine in humans. Drug Alcohol Depend 7-1-2001; 63(2):131-137.
9. Gawin FH, Kleber HD, Byck R, Rounsaville BJ, Kosten TR, Jatlow PI, Morgan C. Desipramine facilitation of initial cocaine abstinence. Arch Gen Psychiatry 1989; 46(2):117-121.
10. Arndt I, Dorozynsky L, Woody G, McLellan AT, O'Brien CP. Desipramine treatment of cocaine abuse in methadone maintenance patients. NIDA Res Monogr 1989; 95:322-323.
11. Kosten TR, Schumann B, Wright D, Carney MK, Gawin FH. A preliminary study of desipramine in the treatment of cocaine abuse in methadone maintenance patients. J Clin Psychiatry 1987; 48(11):442-444.
12. Kosten T, Gawin FH, Silverman DG, Fleming J, Compton M, Jatlow P, Byck R. Intravenous cocaine challenges during desipramine maintenance. Neuropsychopharmacology 1992; 7(3):169-176.
13. Ziedonis DM, Kosten TR. Pharmacotherapy improves treatment outcome in depressed cocaine addicts. J Psychoact Drugs 1991; 23(4):417-425.
14. Giannini AJ, Malone DA, Giannini MC, Price WA, Loiselle RH. Treatment of depression in chronic cocaine and phencyclidine abuse with desipramine. J Clin Pharmacol 1986; 26(3):211-214.
15. Carroll KM. Integrating psychotherapy and pharmacotherapy to improve drug abuse outcomes. [Review] [70 refs.]. Addict Behav 1997; 22(2):233-245.
16. Kosten TR, Falcioni J, Oliveto A, Feingold A. Depression predicts higher rates of heroin use on desipramine with buprenorphine than with methadone. Amer J on Addict (in press).
17. Silverman K, Higgins ST, Brooner RK, Montoya ID, Cone EJ, Schuster CR, Preston KL. Sustained cocaine abstinence in methadone maintenance patients through voucher-based reinforcement therapy. Arch Gen Psychiatry 1996; 53(5):409-415.
18. Silverman K, Chutuape MA, Bigelow GE, Stitzer ML. Voucher-based reinforcement of cocaine abstinence in treatment-resistant methadone patients: effects of reinforcement magnitude. Psychopharmacologia 1999; 146(2):128-138.
19. Dallery J, Silverman K, Chutuape MA, Bigelow GE, Stitzer ML. Voucher-based reinforcement of opiate plus cocaine abstinence in treatment-resistant methadone patients: effects of reinforcer magnitude. Exp Clin Psychopharmacol 2001; 9(3):317-325.
20. Downey KK, Helmus TC, Schuster CR. Treatment of heroin-dependent poly-drug abusers with contingency management and buprenorphine maintenance. Exp Clin Psychopharmacol 2000; 8(2):176-184.
21. Griffith JD, Rowan-Szal GA, Roark RR, Simpson DD. Contingency management in outpatient methadone treatment: a meta-analysis. Drug Alcohol Depend 2-1-2000; 58(1-2):55-66.
22. Brannon SE, Nelson RO. Contingency management treatment of outpatient unipolar depression: a comparison of reinforcement and extinction. J Consult Clin Psychol 1987; 55(1):117-119.
23. Kosten TR, Oliveto A, Feingold A, Poling J, Sevarino K, McCance-Katz E, Stine S, Gonzalez G, Gonsai K. Desipramine and contigency management for cocaine and opiate dependence in buprenorphine mantained patients. Drug Alcohol Depend 2003; 70:315-325.
24. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV. Washington, DC: American Psychiatric Association Press, 1995.
25. Kosten TR, Schottenfeld R, Ziedonis D, Falcioni J. Buprenorphine versus methadone maintenance for opioid dependence. [see comments]. J Nerv Ment Dis 1993; 181(6):358-364.
26. Kosten TR, Morgan CM, Falcione J, Schottenfeld RS. Pharmacotherapy for cocaine-abusing methadone-maintained patients using amantadine or desipramine. Arch Gen Psychiatry 1992; 49(11):894-898.
27. McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, Pettinati H, Argeriou M. The fifth edition of the addiction severity index. J Subst Abuse Treat 1992; 9(3):199-213.
28. McLellan AT, Luborsky L, Woody GE, O'Brien CP. An improved diagnostic evaluation instrument for substance abuse patients. The addiction severity index. J Nerv Ment Dis 1980; 168(1):26-33.
29. Radloff LS. A CES-D Scale: a self-reported depression scale for reaserch in the general population. Appl Psychol Meas 1977; 1:385-401.
30. Hamilton MA. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62.
31. Proelss HF, Lohmann HJ, Miles DG. High-performance liquid-chromatographic simultaneous determination of commonly used tricyclic antidepressants. Clin Chem 1978; 24(11):1948-1953.
32. Kaplan EL, Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc 1958; 53:457-481.
33. Peto R, Peto J. Asymptomatically efficient rank invariant test procedures. J R Stat Soc [A] 1972; 135:185-207.
34. Bryk AS, Raudenbush SW. Application of heirarchical linear models to assessing change. Psychol Bull 1987; 101:147-158.
35. Gibbons RD, Hedeker D, Elkin I, Waternaux C, Krarmer HC, Greenhouse JB, Shea MT, Imber SD, Sotsky SM, Watkins JT. Some conceptual and statistical issues in analyses of longitudinal psychiatric data. Arch Gen Psychiatry 1993; 50:739-750.
36. Kosten TR, Gawin FH, Morgan C, Nelson JC, Jatlow P. Evidence for altered desipramine disposition in methadone-maintained patients treated for cocaine abuse. Am J Drug Alcohol Abuse 1990; 16(3-4): 329-336.
37. Weiss RD. Relapse to cocaine abuse after initiating desipramine treatment. JAMA 11-4-1988; 260(17):2545-2546.